Literature DB >> 34049663

Evidence Base for Treatment of Infectious Bovine Keratoconjunctivitis.

Annette M O'Connor1, Mac Kneipp2.   

Abstract

In this article, the evidence base for treating infectious bovine keratoconjunctivitis (IBK) is discussed. First, we summarize the available evidence for antibiotic treatments registered in North America. We then discuss the evidence base for nonantibiotic alternatives. We do not discuss antibiotic treatments that do not use registered protocols; such information is available in another review. Finally, we discuss how the research community could generate more evidence for effective treatments and the comparative efficacy information to help veterinarians and producers decide between treatment options.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotics; Infectious Bovine Keratoconjunctivitis; Randomized control trials study design; Treatments

Year:  2021        PMID: 34049663     DOI: 10.1016/j.cvfa.2021.03.008

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN: 0749-0720            Impact factor:   3.357


  1 in total

1.  Whole genome sequencing of Moraxella bovis strains from North America reveals two genotypes with different genetic determinants.

Authors:  Emily L Wynn; Matthew M Hille; John Dustin Loy; Gennie Schuller; Kristen L Kuhn; Aaron M Dickey; James L Bono; Michael L Clawson
Journal:  BMC Microbiol       Date:  2022-10-21       Impact factor: 4.465

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.